Company profile
BECTON DICKINSON & CO
NYSE:BDXMedical/Dental Instruments
Drug pipeline (4)
| Asset | Stage | Revenue | Trials | Status |
|---|---|---|---|---|
| Chlorhexidine Gluconate | approved | — | 7 | approved |
| HEXACHLOROPHENE | approved | — | 0 | — |
| Isopropyl alcohol | approved | — | 0 | — |
| POVIDONE-IODINE | approved | — | 0 | — |
Revenue is the latest reported period from SEC filings. A combination product's amount appears on each of its constituent assets, so those rows are not additive.
Clinical trials (10)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03224299 | phase2 | completed | 2017-06-21 | 2017-08-24 | Becton, Dickinson and Company | Effectiveness of an Antimicrobial Agent for Preoperative Skin Preparation |
| NCT03140254 | phase2 | completed | 2016-09-01 | 2017-03-17 | C. R. Bard | Evaluating Safety and Effectiveness of Octenidine Dihydrochloride |
| NCT03229759 | phase2 | completed | 2017-06-21 | 2017-08-04 | Becton, Dickinson and Company | Evaluation of the Antimicrobial Effectiveness of an Antimicrobial Cloth |
| NCT00553488 | phase2 | completed | 2007-09-01 | 2007-12-01 | Becton, Dickinson and Company | Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating |
| NCT00692484 | phase3 | completed | 2007-10-01 | 2008-02-01 | C. R. Bard | Pilot Evaluation of the Application Procedure on the Antimicrobial Effects of 2 Antiseptics |
FDA applications (7)
| Application | Type | Applicant | Products | |||
|---|---|---|---|---|---|---|
| ANDA 072525 | ANDA | BECTON DICKINSON AND CO | ||||
Loading… | ||||||
| ANDA 073416 | ANDA | BECTON DICKINSON SURGICAL SYSTEM | ||||
Loading… | ||||||
| NDA 017452 | NDA | BECTON DICKINSON AND CO | ||||
Loading… | ||||||
| NDA 019240 | NDA | BECTON DICKINSON AND CO | ||||
Loading… | ||||||
| NDA 019476 | NDA | BECTON DICKINSON AND CO | ||||
Loading… | ||||||